Table 2.
Clinical characteristics of patients with and without LMWH prophylaxis. Data are reported as mean ± SD for continuous variables and % for categorical variables
| Patients With Lmwh Prophylaxis | Patients Without Lmwh Prophylaxis | P | |
|---|---|---|---|
| N | 251 | 1532 | - |
| Age (years) | 77 ± 13 | 70 ± 16 | < 0.001 |
| Age > 70 years, n (%) | 184 (73%) | 866 (56%) | < 0.001 |
| Female, n (%) | 130 (52%) | 710 (46%) | 0.110 |
| BMI (Kg/m2) | 26 ± 5 | 27 ± 5 | 0.23 |
| Current Smoking, n (%) | 54 (21%) | 339 (22%) | 0.824 |
| Diabetes, n (%) | 68 (7%) | 391 (25%) | 0.598 |
| Hypertension, n (%) | 173 (69%) | 945 (62) | 0.028 |
| Myocardial infarction or STROKE, n (%) | 53 (21%) | 215 (14%) | 0.004 |
| Acute infection, n (%) | 103 (41%) | 477 (31%) | 0.002 |
| Pneumonia, n (%) | 69 (27%) | 194 (13%) | < 0.001 |
| Active cancer, n (%) | 48 (19%) | 221 (14%) | 0.054 |
| History of VTE, n (%) | 15 (6%) | 52 (3.4%) | 0.127 |
| Reduced mobility, n (%) | 178 (70%) | 328 (21%) | < 0.001 |
| Thrombophilia, n (%) | 2 (0.7%) | 12 (0.7%) | 0.982 |
| Kidney failure, n (%) | 66 (26%) | 294 (19%) | 0.009 |
| Heart or respiratory failure, n (%) | 91 (36%) | 330 (21%) | < 0.001 |
| D-dimer (µg/mL)a | 1,93 ± 1,50 | 1,45 ± 1,39 | < 0.0001 |
aPerformed only in patients where D-Dimer has been evaluated